Followers | 16 |
Posts | 4562 |
Boards Moderated | 0 |
Alias Born | 04/13/2016 |
Monday, May 22, 2017 10:03:07 PM
My sense of the numerous posts of late is that very few people have changed their minds as a function of the discussion. I confess to a little 'post fatigue' by seeing largely the same issues rehashed on both sides of the fence. I'm hoping we might all just move on.
Two more issues. First, TRUTH raised the issue of additional funding for Notre Dame, which apparently has a near-term end date. He speculated that KBLB might be switching to a different scientific team. I'm going to suggest a different direction: I believe the recent rounds of genetic modifications, leading to four new strains we have not heard much of, weren't as successful as KBLB hoped. KBLB is therefore paying for an additional round of genetic insertions. The extension is short-term because that is all KBLB can pay for at this point.
Again I call attention to the speculative nature of my claim. I don't have any evidence in support of this idea.
My final issue is something that I didn't see in the latest quarterly report, but may have overlooked. Did they report expenditures to cover travel to Vietnam? I don't recall seeing those charges listed. Also, I've not seen much in the way of operations for their silkworm rearing facility. Do we know how much this is costing them?
Unless I overlooked these expenses, I'm guessing that Kim Thompson paid for these out-of-pocket. That could be a part of the $2m+ he is owed on the books.
If so, it speaks to Mr. Thompson's unwillingness to dilute stock through sales to Calm Seas and also his confidence that KBLB will turn profitable soon.
Any thoughts? I'm not as good at reading financial reports as others on this board.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/16/2024 09:00:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:30:52 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM